{"name":"PureTech","slug":"puretech","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi1AJBVV95cUxOdm90RzFBMHJuOEwya29VbGhyb2dLMTRscWFmSzdjN0F2LVpGMENiYVE5MXZRbXIxdVNJMU84VXdQY04yREFZbkE4QmVjdlkxTVZEZzdSSF9xYzF1SGl4aDBRV2N3OW9qNU5uNzFRa09LZUJkWWVrQlJ0VHVPR0dnMFRmMDBQOF82ZTlKak94WUhCelhNeFFIa0ZkdlhzUHl4c3VEUlotWUxiMmxnNndhQUY2QVQ4TWxMeTRycTFIbFFqVlpMcHg3b0IwUE9Ya19hSmUwaElxaGdNWDNDRk5CVUxzb0N3R3p5dXQ1c21sanYzYXhWSmpJenkwUGxqUHRMTlpDMy1JYl9KV3B2dTZtU29kdzg4LXNaLXNWRkdGemZoa19pQTQ5aWlNbE50MmZwMFhfdlduZ3VlZVZ1Qk1WaV9VcVBLal9JaWN5U2VwMFdVLUl0?oc=5","date":"2026-02-26","type":"regulatory","source":"Barchart.com","summary":"Pulmonary Fibrosis Pipeline 2025: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment by DelveInsight | Boehringer Ingelheim, PureTech, Guangzhou JOYO Pharma, Tvardi Therapeutics ","headline":"Pulmonary Fibrosis Pipeline 2025: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment by DelveInsig","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPbFM2dFgtN29vb0VYLW1LVnplLVctS2psSlc4eFhQWnlOOURWMzR0R1ZwSmlLRVdPTmlSYXpjZThTT1NLZGllNWxWYUVPMHlfNG9DS3lOT3ZwNkpCQ250RzBJNVJYenhXSFJaYkpRREFSSDQtVXVfNW02Wm1JYWRMd1VQaUR1YW04YkdyLVNORkNpSFNxRWRHRFlSb1Q?oc=5","date":"2025-08-26","type":"pipeline","source":"The Pharma Letter","summary":"PureTech announces the launch of Celea Therapeutics - The Pharma Letter","headline":"PureTech announces the launch of Celea Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxPanhjYndnQ2cyZ1hWZGdlanR5WEhLWnVYdGRLUDBSYVJpMG45Sk0xdUhyeW1TN053MlR2bXdHMzBnbk5USGhhMHgyWXdiTlFuNGJVaWk0dUZGSDlieG13TUdBa2toUDlfejRPaTk4d2tVdk9MUUdDRzQ1ZG1pWGZCTk5DYmtoWVI2U3NYX0wtaVhrWElQdXVQTzlYREpHaXVNTUJ2N0NKTGY5T0VRVE85VA?oc=5","date":"2025-08-14","type":"trial","source":"BioPharma Dive","summary":"Vedanta, PureTech’s microbiome startup, to cut staff after study setback - BioPharma Dive","headline":"Vedanta, PureTech’s microbiome startup, to cut staff after study setback","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxNWlVGdDN2UzQwLVo4Uy13Nkx5dFBJcnltRHZJNlYxRXF6b1RuOWRVcmYxQ2VGUnZUTjlDdkF2RkNxaU9XYjZ6RVNVbThkSHZodnJ1MFdQNXJDVkc1UkRnT0lNUG9YRHc4WG1ZWWxaemhkU18xck85ZzExZmVvRjg2TEktalJCSFNPV3E5OVlZaDFTX3ZyMlI0SDRIdw?oc=5","date":"2025-08-13","type":"pipeline","source":"Pharmaceutical Technology","summary":"PureTech forms respiratory spin-off Celea to advance deuterated pirfenidone - Pharmaceutical Technology","headline":"PureTech forms respiratory spin-off Celea to advance deuterated pirfenidone","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxPcGxCNHNfbUJaeVRtaV84dTBjbXNQQmdzUGpXWEsyWjdsZ3dnRER3RFlFdG9jNWxQZFNZdThteUJ6SGlWdTY2bEJaSkFKRTM3X3pLWllMbVowX0JZMjl3WHl6dUJjUUgzV1lXMUN5alg3eTdWZDBfNFdkbHd0b0ZkRldmSQ?oc=5","date":"2025-08-13","type":"pipeline","source":"pharmaphorum","summary":"PureTech launches lung disease specialist Celea - pharmaphorum","headline":"PureTech launches lung disease specialist Celea","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxNWXI1SV82R0xwRWtCX2dvWC05cERkRGRpS3F2aWhDZVBnZW94WFNlZ0J3bFJ2cTNQR3pVOGEtRkJ1SFhpT2dhdjJJemdmUE83cmhmdlYyWWhQTk9peUs0Z1hJTVo0Y05ETVVBa0hfS2pEZVI1M3pWc2tiMnNzdUhhei1mQXpYdHE0eko3dXdrMW9ySTRqcElQQjh5U0xIYThBRjFyWXYxY1Mzc2FKRUdqYkZqUWlQOG12OGZaN1BuQQ?oc=5","date":"2025-08-12","type":"pipeline","source":"BioPharma Dive","summary":"PureTech launches new biotech built around lung disease drug - BioPharma Dive","headline":"PureTech launches new biotech built around lung disease drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE5fYXdQaXRPYk9pXzBLQmJXa0ZpOGJMaUdwT3FXMVZVZUlFa1Nsb0xKZ0V3OG1DSHFqYkQwcFdRc0Z6Z3VQa2JGT19hUnZpTUZlelk4?oc=5","date":"2025-08-12","type":"pipeline","source":"FirstWord Pharma","summary":"PureTech spins out new lung disease unit to advance IPF candidate - FirstWord Pharma","headline":"PureTech spins out new lung disease unit to advance IPF candidate","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxOeW1fZEgtaGN5Y29tMHpWcE5OQlU3aEJYa1RseFE1QmlFZEtoWmhpUlNZZG1VT3dBR3d2M3FLVXo3MEhfWHV4NHctMkt2cEVkZENoSHlta2o5TXdUZ1ZaSUxoSjRMRUhZYjQ1VUFYYmN3UlhRYW1UVGZCT25CNng0ZGR0dk5PR2pNYW4tMF9KUTVuRGZDQW90T3pOY2ZPWkhCU2FiLWhENEJORGswblM5cG5HUXU5LWVNV1hCYW1Bazc?oc=5","date":"2025-08-12","type":"pipeline","source":"European Pharmaceutical Review","summary":"PureTech taps ex-Teva CEO to run its new respiratory unit Celea - European Pharmaceutical Review","headline":"PureTech taps ex-Teva CEO to run its new respiratory unit Celea","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxNQmlqWmVmcUdUMnU4UFBXVVk4Ynh5VHAzaTJnWWlCUktjY1VaVkhBUGtOVlFVbmwxWm8xaTFhRUNFX0w3SGJpd210THFVNG1iTWxneVpJX1BmY010cE5pWmwtcnFISXc5dHJkRnJ3UHRONVNTU0dUSUQ4a3RSZlBpc2h3U2VZaHNobGZQU3Q0TDczQlIzLXdYbXVsTDN0Q0MtX3EzSjRrSlIwWWZ5UlRLSGUtQnd1cE1UZGgw?oc=5","date":"2025-08-12","type":"pipeline","source":"fiercebiotech.com","summary":"PureTech launches Celea Therapeutics to develop highly touted lung disease candidate - fiercebiotech.com","headline":"PureTech launches Celea Therapeutics to develop highly touted lung disease candidate","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-06-06","type":"trial","source":"Express Pharma","summary":"PureTech’s LYT-100 holds potential to expand treatment options for idiopathic pulmonary fibrosis: GlobalData - Express Pharma","headline":"PureTech’s LYT-100 holds potential to expand treatment options for idiopathic pulmonary fibrosis: GlobalData","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwJBVV95cUxQNHRWcW5VcFpaRjlWLUpkbFlMOVA0Zy1zV29xVXpjRzVEUFprbS1KUDZGSnJseXJUY2FtckJtQlV2Uk5lZFVPTzVWME8yaWVZcy1pQnAxb2pnTnZJNjVuWXM3QjVuaWtleEVKLTNoTy14QTladUxfTHgySzFfU3dhS2FkMVRidzFNenJRTDc0aWtFSDVxSUxLdm84U1lDWDRFRldSYjJmMXBIYXBNYlU3V3FRZmhodDdqdGMxZm9HaklLcjdPcXNBWVdTWlpWRVhGNTF5dUtoLWlqd1dPeHBFRTQ0N3djbFZ1VVU2dkRMZ1JjTTB2d2F1a2dqNUE5c3E0d0s4MVlBTQ?oc=5","date":"2024-04-08","type":"pipeline","source":"businesswire.com","summary":"PureTech Launches Seaport Therapeutics with $100 Million Oversubscribed Series A and Announces Management Transitions - businesswire.com","headline":"PureTech Launches Seaport Therapeutics with $100 Million Oversubscribed Series A and Announces Management Transitions","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxOZGl4ZXUycGRkWEM1UHRyemIzSmFVQ2JoLUp2T2FVSXNvWl96WnNMRG5kOVduMm5aa0dSUllMS2NVakw3dmVWR3lRQTVCQkVtbXlRTkUwSnFuN2NfVktxdmpQZ3BwOGZpTEYzcGV6cm8tNGVDV1Q2Z1FpUU9Dbi1ZMDFId2pjSmxyV2tVOWpfTjJ6N0dyS3VPYUlsUGxfX1JfUGNsVw?oc=5","date":"2022-12-01","type":"pipeline","source":"Fierce Pharma","summary":"PureTech readies oral CBD capsule for clinic to challenge Jazz's Epidiolex - Fierce Pharma","headline":"PureTech readies oral CBD capsule for clinic to challenge Jazz's Epidiolex","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}